erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abscess D000038 13 associated lipids
Peritonsillar Abscess D000039 1 associated lipids
Acne Vulgaris D000152 35 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Actinomycosis, Cervicofacial D000197 1 associated lipids
Adenocarcinoma D000230 166 associated lipids
Agammaglobulinemia D000361 4 associated lipids
Airway Obstruction D000402 13 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Anemia, Hemolytic, Autoimmune D000744 5 associated lipids
Anemia, Hypochromic D000747 5 associated lipids
Angiomatosis D000798 1 associated lipids
Animal Diseases D000820 2 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Aortic Valve Stenosis D001024 4 associated lipids
Spider Bites D001098 1 associated lipids
Arthritis D001168 41 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Carbonell N et al. Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. 2006 Am. J. Gastroenterol. pmid:16771939
Glupczynski Y and Burette A Failure of azythromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment. 1990 Am. J. Gastroenterol. pmid:2153337
Maganti K et al. Oral erythromycin and symptomatic relief of gastroparesis: a systematic review. 2003 Am. J. Gastroenterol. pmid:12591038
Janssen P et al. The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. 2013 Am. J. Gastroenterol. pmid:24005344
Chang AD et al. Bacillary angiomatosis associated with extensive esophageal polyposis: a new mucocutaneous manifestation of acquired immunodeficiency disease (AIDS). 1996 Am. J. Gastroenterol. pmid:8855753
VIRANUVATTI V and BISESHURARIT P Clinical trial of erythromycin in amebic liver abscess. 1955 Am. J. Gastroenterol. pmid:13228406
Hakkal HG Pseudomembraneous colitis associated with antibiotics. 1976 Am. J. Gastroenterol. pmid:1274934
Jones KL et al. The effect of erythromycin on gastric emptying is modified by physiological changes in the blood glucose concentration. 1999 Am. J. Gastroenterol. pmid:10445530
Fiorucci S et al. Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term. 1994 Am. J. Gastroenterol. pmid:8147358
Resnick J et al. Delayed gastric emptying and postoperative ileus after nongastric abdominal surgery: part II. 1997 Am. J. Gastroenterol. pmid:9177505
Camilleri M The current role of erythromycin in the clinical management of gastric emptying disorders. 1993 Am. J. Gastroenterol. pmid:8424415
Keshavarzian A and Isaac RM Erythromycin accelerates gastric emptying of indigestible solids and transpyloric migration of the tip of an enteral feeding tube in fasting and fed states. 1993 Am. J. Gastroenterol. pmid:8424419
Mantides A et al. The effect of erythromycin in gastric emptying of solids and hypertonic liquids in healthy subjects. 1993 Am. J. Gastroenterol. pmid:8424420
Richards RD et al. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. 1993 Am. J. Gastroenterol. pmid:8424421
Bonacini M et al. Effect of intravenous erythromycin on postoperative ileus. 1993 Am. J. Gastroenterol. pmid:8424422
Ruffin WK Erythromycin: a postoperative jumpstart? 1994 Am. J. Gastroenterol. pmid:7909647
CURTIN JA THE EFFECT OF ANTIBIOTICS UPON THE GASTROINTESTINAL TRACT. 1964 Am. J. Gastroenterol. pmid:14206198
McNulty CA The treatment of Campylobacter-associated gastritis. 1987 Am. J. Gastroenterol. pmid:3493685
Koutsoumbi P et al. The effect of erythromycin on human esophageal motility is mediated by serotonin receptors. 2000 Am. J. Gastroenterol. pmid:11151866
Portincasa P et al. The effect of acute oral erythromycin on gallbladder motility and on upper gastrointestinal symptoms in gastrectomized patients with and without gallstones: a randomized, placebo-controlled ultrasonographic study. 2000 Am. J. Gastroenterol. pmid:11151875
Ecker JA et al. Pseudomembraneous enterocolitis--an unwelcome gastrointestinal complication of antibiotic therapy. 1970 Am. J. Gastroenterol. pmid:4319211
Moussa F et al. Erythromycin eye ointment: effect on gastrointestinal motility. 2000 Am. J. Gastroenterol. pmid:10710093
Kalkay MN et al. Campylobacter-induced toxic megacolon. 1983 Am. J. Gastroenterol. pmid:6613968
Masclee AA et al. Effect of erythromycin on gallbladder emptying in patients with antrectomy or truncal vagotomy. 1995 Am. J. Gastroenterol. pmid:7771433
Laine L and Jensen DM Management of patients with ulcer bleeding. 2012 Am. J. Gastroenterol. pmid:22310222
Slotkin RI et al. The effect of antibiotics on Mycoplasma pneumoniae in vitro and in vivo. 1967 Am. J. Epidemiol. pmid:5006447
Heggie AD et al. Topical sulfacetamide vs oral erythromycin for neonatal chlamydial conjunctivitis. 1985 Am. J. Dis. Child. pmid:3890519
Patamasucon P et al. Oral v topical erythromycin therapies for chlamydial conjunctivitis. 1982 Am. J. Dis. Child. pmid:7051813
Derrick CW and Dillon HC Erythromycin therapy for streptococcal pharyngitis. 1976 Am. J. Dis. Child. pmid:766615
BURNS L and HODGMAN J STUDIES OF PREMATURES GIVEN ERYTHROMYCIN ESTOLATE. 1963 Am. J. Dis. Child. pmid:14057607
Bass JW et al. Antimicrobials in the treatment of acute otitis media. A second clinical trial. 1973 Am. J. Dis. Child. pmid:4632555
Pai CH et al. Erythromycin in treatment of Campylobacter enteritis in children. 1983 Am. J. Dis. Child. pmid:6600579
Disney FA and Pichichero ME Treatment of Staphylococcus aureus infections in children in office practice. 1983 Am. J. Dis. Child. pmid:6600877
Lloyd-Still JD et al. Erythromycin estolate hepatotoxicity. 1978 Am. J. Dis. Child. pmid:629252
Wannamaker LW Perplexity and precision in the diagnosis of streptococcal pharyngitis. 1972 Am. J. Dis. Child. pmid:5056872
Fischer PR and Shigeoka AO Familial occurrence of Stevens-Johnson syndrome. 1983 Am. J. Dis. Child. pmid:6604452
Demidovich CW et al. Impetigo. Current etiology and comparison of penicillin, erythromycin, and cephalexin therapies. 1990 Am. J. Dis. Child. pmid:2244610
Ginsburg CM et al. Erythromycin therapy for group A streptococcal pharyngitis. Results of a comparative study of the estolate and ethylsuccinate formulations. 1984 Am. J. Dis. Child. pmid:6372437
Esterly NB et al. Impetigo. 1991 Am. J. Dis. Child. pmid:1899777
Sprauer MA et al. Prevention of secondary transmission of pertussis in households with early use of erythromycin. 1992 Am. J. Dis. Child. pmid:1733147
Robins-Browne RM et al. Treatment of Campylobacter-associated enteritis with erythromycin. 1983 Am. J. Dis. Child. pmid:6337473
Barton LL and Friedman AD Etiology and therapy of impetigo: reconsidered. 1990 Am. J. Dis. Child. pmid:2305731
Warkany J A warfarin embryopathy? 1975 Am. J. Dis. Child. pmid:1121959
Davis SD et al. Partial antibiotic therapy in Haemophilus infuenzae meningitis. Its effect on cerebrospinal fluid abnormalities. 1975 Am. J. Dis. Child. pmid:1080009
Wittler RR et al. Penicillin tolerance and erythromycin resistance of group A beta-hemolytic streptococci in Hawaii and the Philippines. 1990 Am. J. Dis. Child. pmid:2184661
Lascari AD et al. Varicella-like rash associated with Mycoplasma infection. 1974 Am. J. Dis. Child. pmid:4855375
Halsey NA et al. Nosocomial pertussis: a failure of erythromycin treatment and prophylaxis. 1980 Am. J. Dis. Child. pmid:7377164
Noonan JA et al. Cerebral and cardiac complications from bacterial endocarditis. A successfully managed case with unusual complications. 1968 Am. J. Dis. Child. pmid:5303294
Bruhn FW Lyme disease. 1984 Am. J. Dis. Child. pmid:6711502
Bass JW et al. Susceptibility of Bordetella pertussis to nine antimicrobial agents. 1969 Am. J. Dis. Child. pmid:4303822